Sanofi India Limited
SANOFI
LTP
N/A
Latest Quarter Update
Strong Growth in Diabetes Segment Strategic initiatives drive performance
Diabetes Segment Revenue Growth
10% YoY growth
₹Y billion
Launch of Soliqua exceeding initial expectations
Partnerships with Emcure and Cipla enhancing distribution
Earning Calls History
Q2 FY2024 - May 16, 2024
Latest
Sanofi India reported a stable performance in Q1 2024, driven by strategic initiatives across its diabetes and consumer healthcare segments. The successful launch of Soliqua marks a significant advancement in their product offerings, positioning the company for future growth.